FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback